Gene Therapy For Inherited Blood Disorders Yields Significant Benefits In Clinical Trials.

June 18, 2018

STAT (6/15, Feuerstein) reported Bluebird Bio’s LentiGlobin “gene therapy for inherited blood disorders yielded significant benefits for patients, according to updated results from ongoing clinical trials.” The gene therapy is being tested as a treatment...